| Literature DB >> 35956714 |
Evgeniy A Titov1, Larisa M Sosedova1, Mikhail A Novikov1, Marina V Zvereva2, Viktor S Rukavishnikov1, Oleg L Lakhman1.
Abstract
The acute and subacute toxicity of a newly synthesized silver selenide nanoparticles encapsulated in a natural polymeric matrix of arabinogalactan study has been studied. The nanocomposite is a promising material for the design of diagnostic and therapeutic drugs. It can also be used for the preparation of fluorescent labels and in thermal oncotherapy. The employment of binary nanocomposites enables one to unveil the potential hidden in metals which constitute these composites. The study of acute toxicity, carried out by the oral administration of nanocomposites at a dose of 2000 mg/kg, has shown that the compound belongs to low-toxic substances of the 5th hazard class. With the subacute oral administration of nanocomposites at a dose of 500 μg/kg, slight changes are observed in the brain tissue and liver of experimental animals, indicating the development of compensatory-adaptive reactions. In the kidneys, the area of the Shumlyansky-Bowman chamber decreases by 40.5% relative to the control group. It is shown that the application of the protective properties of selenium, which is contained in the composite, helps to reduce the toxicity of silver.Entities:
Keywords: brain; kidney; laboratory animals; liver; morphology; nanocomposite; silver selenide; toxicity
Year: 2022 PMID: 35956714 PMCID: PMC9370907 DOI: 10.3390/polym14153200
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1Fragment of AG macromolecule [18].
Figure 2(a)—Microphotograph and particle size distribution (inset) of Ag2Se nanoparticles in AG polysaccharide matrix; (b)—diffractogram of Ag2Se-AG nanocomposite (4%w Ag2Se); (c)—absorption spectrum of 0.1% of Ag2Se-AG nanocomposite (4%w Ag2Se) water solution and its Tauc plot of (αhν)2 vs. (hν) (inset).
Increase in body weight of white mice of the experimental and control groups that survived intoxication with the Ag2Se-AG nanocomposite.
| Groups | Before Injection | One Week after Injection | Two Weeks after Injection |
|---|---|---|---|
| Experimental | 32.3 ± 0.55 | 32.5 ± 0.56 | 33.5 ± 0.56 |
| Control | 31.8 ± 0.79 | 32.0 ± 0.77 | 33.0 ± 0.73 |
Morphometric parameters of the sensorimotor zone of the cerebral cortex, liver and kidney tissues during subacute administration of the Ag2Se-AG nanocomposite to rats at a dose of 500 μg/kg of body weight for 10 days. Me (Q25–Q75).
| Indicators | Experimental Group | Control Group |
|
|---|---|---|---|
| Sensorimotor Area of the Cerebral Cortex | |||
| Number of normal neurons per unit area | 117.0 (110.0–145.0) | 152.0 (133.0–177.0) | 0.2 |
| Number of astroglial cells per unit area | 140.0 (119.0–158.0) | 156.0 (119.0–164.0) | 0.85 |
| Number of degeneratively altered neurons per unit area | 8.0 (7.0–15.0) | 5.0 (5.0–6.0) | 0.08 |
| Number of neuronophagy | 4.0 (2.0–5.0) * | 1.5 (1.0–2.0) | 0.05 |
| Liver | |||
| Number of Kupffer stellate macrophages | 167.5 (140.0–192.0) | 145.0 (141.0–148.0) | 0.55 |
| Number of polynuclear hepatocytes | 19.5 (19.0–26.0) * | 16.0 (11.0–18.0) | 0.04 |
| Kidney | |||
| Shumlyansky–Bowman capsule area | 27,715.5 (24,260.9–31,714.8) * | 32,556.5 (28,573.1–36,306.2) | 0.02 |
Notes: * differences are statistically significant compared to the control according to the Mann–Whitney test, p ≤ 0.05.
Figure 3Microphoto of brain tissue of white rats of experimental (A) and control (B) groups. ↑—degeneratively altered neuron. Hematoxylin–eosin. Mag. ×400.
Figure 4Microphoto of liver tissue of white rats of experimental (A) and control (B) groups. okr. Hematoxylin–eosin. Mag. ×400.
Figure 5Microphoto of kidney tissue of white rats of experimental (A) and control (B) groups. ↑—Shumlyansky–Bowman chamber. Hematoxylin–eosin. Mag. ×400.